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Lumbar spinal stenosis (LSS) is a clinical condition presenting with back and leg
pain due to the compression of intraspinal vascular and neuronal structures by
narrowed spinal canal. Pain, paresthesia, and cramping in one or both legs,
described as neurogenic claudication, is present in 62% of patients, due to
ischemia the nerve roots.
1-3 Lumbar spinal anteroposterior diameter under 11 mm
and a dural area below 100 mm
2 in imaging procedures depict stenosis.
4-6 However,
as narrowing of the lumbar spinal canal is present in 20% of asymptomatic
individuals, clinical findings are highly important in diagnosis and leg pain
described as neurogenic claudication emerges as a valuable parameter in the
observation of recovery.
7
Conservative treatment is effective in LSS patients with mild or occasionally
moderate pain.
6 Daily life style adjustments, back training, exercise programs to
stretch, strengthening the lumbar region, and general conditioning exercises both
prescribed alone or together with physical therapy yield good clinical results.
8-10
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Purpose: The aim of our study was to compare the efficacy of physical therapy alone and in combination with
calcitonin in patients with neurogenic claudication (NC). Materials and Methods: In this single blind, and
randomized study, patients with lumbar spinal canal stenosis who were diagnosed by clinical findings and MRI and
having NC were included. Patients were observed for 8 weeks and evaluated before and after treatment. Patients
were randomized between the salmon calcitonin 200 U/day + physical therapy (n = 23) (Group 1) and paracetamol
1,500 mg/day + physical therapy (n = 22) (Group 2) treatment groups. Both groups received the same physical
therapy (interferential current + hot pack + short wave diathermy) and exercise protocol. The association of various
clinical and functional parameters was assessed statistically by using paired and unpaired t test, chi square test and
McNemar’s test. p < 0.05 indicated statistical significant. Results: Mean age of the patients in Group 1 was 57.6 ±
11.2 and in Group 2 54.5 ± 10.6 years. Before treatment, there were no significant differences between groups with
respect to age, body mass index, spinal axial diameter, Visual Analogue Scale (VAS), spinal mobility, functional
status and walking distance (p > 0.05). After 8 weeks of treatment, both groups benefited significantly with respect
to VAS, functional status and walking distance (p < 0.001). There was no statistically significant difference
between groups (p > 0.05). Conclusion: In 45 patients with lumbar spinal stenosis who received 8 weeks of
treatment, concomitant use of calcitonin with physical therapy and exercise did not have any benefical effect on the
patient’s pain, functional status, lumbar mobility and walking distance.
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INTRODUCTIONCalcitonin is a hormone secreted by the para-follicular
cells of the thyroid, and used in the treatment of osteopo-
rosis and Paget’s disease. Due to its analgesic effect, it has
also been used in LSS. Analgesic efficacy is considered to
be through an increase of beta endorphin levels.
11,12 Since
the narrowing of the spinal canal is the result of soft tissue
hypertrophy and edema, its success in treatment is due to
anti-inflammatory and anti-edematous efficacy of calcito-
nin.
13 Baker, et al.
14 reported that, the deterioration of micro-
circulation in older patients causes neurogenic claudication
in degenerative spinal stenosis, and calcitonin produces a
decline in symptoms through its arterial dilator effect.
The aim of our study was to evaluate in a short term the
effect of physical therapy alone and in combination with
calcitonin on pain, physical examination results and the
functional status of patients with neurogenic claudication,
and diagnosis of lumbar spinal stenosis. 
Patients referred to our outpatient clinic with lower back
and leg pain, which described neurogenic claudication, and
was diagnosed as LSS by physical examination and imag-
ing studies were included in the study. 
Clinical diagnosis criteria
15-17 
1) Pain in one or both legs after walking, diminishing of
pain upon sitting or bending forward, and increase of pain
with activities that increased extension of the spine such as
descending stairs, 2) Restriction of spinal extension and
pain in the low back/leg determined physical examination. 
In order to exclude the presence of arterial claudication
during physical examination, care was taken to ascertain
palpable peripheral pulse and the absence of trophic disor-
ders due to arterial insufficiency. Neurogenic claudication
was also confirmed by the bicycle test. In the bicycle test,
patients mounted on a static bicycle (Tunturi Static Bicycle)
and instructed to push pedals for 5 minutes at a tolerable
resistance.
18 The absence of leg pain was evaluated in favor
of neurogenic claudication. 
Radiological diagnosis criteria 
After clinical assessment, patients with the narrowest level
or levels with an axial diameter below 10 mm, measured
by lumbar MRI, were included in the study by a definition
of absolute stenosis, while those with an axial diameter of
10-12 mm were included by the definition of relative ste-
nosis in the presence of clinical findings.
19
Exclusion criteria
Worsening of motor weakness, patients with bladder/gut
dysfunction, previous spinal surgery, presence of inflamma-
tory, infectious, or metastatic disease, neurological diseases
affecting ambulation ability (such as stroke, Parkinsonism,
peripheral entrapment neuropathy, etc), knee pain affecting
ambulation ability, hip osteoarthritis, lower extremity peri-
pheral arterial insufficiency, and current calcitonin use for
osteoporosis. 
In this single blind and randomized study, patients were
consecutively randomized into 2 groups. Group 1 received
200 U/day intranasal calcitonin, while Group 2 received a
maximum of 1,500 mg/day paracetamol. All patients took
part in a physical therapy and exercise program. Physical
therapy consisted of vacuum interference (20 min) + Hot
Pack (20 min) + short wave diathermia (10 min) to the lum-
bar region, 5 days a week for 15 sessions. Exercises con-
sisted of pelvic tilt, abdominal strengthening, hip flexion and
hamstring stretching, and lumbar mobilization exercises.
10
Exercises were taught and performed in the hospital by a
physiotherapist during physical therapy session, and
patients were thereafter recommended to repeat the same
exercises twice a day at home. 
Randomization (FY) and physical examinations (FS)
were carried out by the same physiatrist, thus maintaining
a single-blind design. No financial support was accepted
for the study. The same nasal calcitonin product which
could be obtained easily in the market was prescribed, and
the other group was permitted to take paracetamol as
analgesic. In order to evaluate the analgesic effect of calci-
tonin in a short term, a dosage of 200 U/day was prescribed,
which is the dosage available in our country. All patients
who would use calcitonin were informed about storage
condition of the bottle (before opening, bottles were stored
between 36-46 F in the fridge, and open bottles were stored
at room temperature) and also application style. Patients
were informed not to pump the calcitonin spray after 14
sprays, because each bottle contained 14 sprays. 
Patients were evaluated at baseline and 8 weeks after
treatment. Age, occupation, and Body mass index (BMI) of
patients were recorded. Assessment parameters: 
- Pain (at rest and with movement); patients were req-
uested to evaluate the severity of pain on a 10 mm scale
using the Visual Analogue Scale (VAS).
- Range of motion: measured by lumbar Schober (cm),
finger-to-floor distance (cm), extension (degree-by lumbar
goniometry).
- Functional status: evaluated by the Roland-Morris
Scale.
20
- Walking distance: expressed in meters. 
The 24-item Roland-Morris Scale adapted to Turkish
was used for functional assessment.
20 In this scale, each
item was answered by “yes” or “no”, and “yes” responses
took 1 and “no” responses 0 points, and the total score was
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calculated. A total score of 0 points meant “no disability”,
while a total score of 24 points meant “extremely severe
disability”.
20
Walking distance was measured by a treadmill (Ferrox-
Fulmine Treadmill) at 0
O inclination, with the body at a
vertical position, at a speed of 2 km/h.
21 The test was termi-
nated when patients suffered of leg pain, and walking
distance was determined.  
Statistical analyses were managed by the GraphPad
Prisma V.3 program. Besides descriptive statistical methods
(mean, standard deviation), independent t test in the com-
parison of paired groups, paired t test in the comparison of
repeated measures in paired groups, the χ 2-test in the com-
parison of qualitative data, and the McNemar’s test in the
comparison of repeated measures of qualitative data were
used. Results were accepted significant at p< 0.05.
A total of 45 patients were included in the study. Group 1
consisted of 23, and Group 2 of 22 patients. The most
commonly affected lumbar level was L4-L5, followed by
narrowing at the L3-L4 level (Fig. 1). 
Concomitant diseases were hypertension in 8, diabetes
mellitus in 4, hypercholesterolemia in 4, ischemic heart
disease in 2, and asthma in 1 patient. 
In the group using calcitonin, only one patient had nasal
irritation that did not necessitate cessation of therapy, and
all patients were comfortable with the drug. In the group
using paracetamol, patients used average 1.8 ± 0.8 tablets
(each tablet of 500 mg). All patients who were enrolled in
the study and completed the follow-up protocoland were
included in the analysis.
With respect to baseline values, there was no significant
difference between groups in patients’ age, gender, BMI
values, axial diameter averages, VAS, lumbar ROM, func-
tional status, and walking distance parameters (Table 1).
In the inter-group evaluation performed at week 8,
lumbar Schober was similar in both groups, while the
finger-to-floor distance significantly improved in the
calcitonin group. All other parameters showed significant
improvement in both groups (Table 2).
There was no significant difference between the groups
with respect to improved parameters during the follow up
period as well as their percent changes (Table 3).
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Fig. 1.Level of disease in patients.
Table 1. The Comparison of Patients’ Age, Gender, BMI Values, Axial Diameter Averages and Pre-Treatment
Follow-up Parameters 
Group 1 (n = 23) Group 2 (n = 22) t p
Age 57.65 ± 11.26 54.45 ± 10.66 0.98 > 0.05
Gender   
Male n = 17 (73.9%) n = 14 (63.6%) 0.55* > 0.05
Female n = 6 (26.1%) n = 8 (36.4%)
BMI 27.68 ± 3.27 28.13 ± 2.98 - 0.48 > 0.05
Axial diameter (mm) 10.43 ± 1.73 10.95 ± 1.24 - 1.13 > 0.05
VAS at rest 2.96 ± 2.14 2.59 ± 2.02 0.59 > 0.05
VAS with motion 7.7 ± 1.15 7.55 ± 0.96 0.48 > 0.05
LS (cm) 4.5 ± 0.92 4.39 ± 0.82 0.44 > 0.05
FTF (cm) 7.65 ± 7.93 8.91 ± 9.5 9.50 > 0.05
Ext (degree) 15.65 ± 7.28 17.95 ± 10.31 - 0.87 > 0.05
RM score 17.48 ± 5.28 16.59 ± 5.97 0.53 > 0.05
WD (m) 293.5 ± 206.9 234.1 ± 152.3 2.09 > 0.05
BMI, body mass index; VAS, visual analogue scale; LS, lumbar schober; FTF, finger-to-floor distance; Ext, extension; RM, Roland-Morris 
score; WD, walking distance. 
*χ 2.Fusun Sahin, et al.
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The generally accepted practice for the treatment of LSS is
the use of conservative therapy in mild and moderately
symptomatic patients, and surgery in patients with severe
symptoms.
6,22,23 Another approach in patients in whom con-
servative treatment fails is to perform surgery.
24-26 Naturally,
conservative therapy is the treatment of choice in patients
without motor disturbances and/or bladder or intestinal
dysfunction.
27 Trials examined the natural course of the
disease actually confirm the use of conservative therapy as
the first-line treatment. Johnsson, et al.,
22 in the 49-month
follow-up of 32 patients, determined improvement accord-
ing to VAS, and found improvement in 15% of patients,
no change in 70%, and worsening in 15%. Physical
examination established improvement in 41% of patients,
no change in 41%, and worsening in 18%. Sengupta and
Herkowitz
28 also states in his review that 15% of patients
improved, 30% worsened within 2-3 years and needed
surgery, while 45% were stable for a long time.
Conservative treatment options include physical therapy
and exercise, epidural steroid injections, calcitonin and
other analgesic/anti-inflammatory medications, and these
are usually prescribed in combination.
29 Studies on exercise
treatment particularly emphasize the importance of flexion
exercises, and recommend the addition of general condi-
tioning exercises.
8,10,30 Among trials using conservative
treatment options, Onel, et al.
31 combined physical therapy
with superficial and deep heat with calcitonin, and imple-
mented a one-month inpatient rehabilitation with an aggres-
sive exercise program. Following the one-month observation
period, 70% of patients achieved good outcomes. Simotas,
et al.
32 administered physical therapy to 96%, epidural
steroid injections to 78%, acupuncture to 58%, and orthesis,
bed rest, transcutanous electrical nerve stimulation (TENS)
and manipulation to decreasing percentages of 40 patients
with LSS, and observed decrease in especially pain para-
meters but no changes in functional assessments (walking
distance, walking frequency) after a follow-up of average
Table 2. Comparison of Pre-Treatment and Post-Treatment Assessments in Group 1 and Group 2
Pre-treatment Post-treatment t p
VAS at rest
Group 1 2.96 ± 2.14 1.22 ± 1.2 4.16 < 0.0001
Group 2 2.59 ± 2.02 1.18 ± 0.96 4.49 < 0.0001
VAS with motion
Group 1 7.7 ± 1.15 4.13 ± 2.16 7.59 < 0.0001
Group 2 7.55 ± 0.96 3.55 ± 1.84 11.1 < 0.0001
LS (cm)
Group 1 4.5 ± 0.92 4.6 ± 1.02 -0.69 > 0.05
Group 2 4.39 ± 0.82 4.51 ± 0.5 -0.31 > 0.05
FTF (cm)
Group 1 7.65 ± 7.93 4.43 ± 5.2 2.2 < 0.05
Group 2 8.91 ± 9.5 6.6 ± 6.8 1.9 > 0.05
Ext (degree)
Group 1 15.7 ± 7.3 27.8 ± 10.4 -5.85 < 0.0001
Group 2 17.9 ± 10.3 28.4 ± 10.3 -5.7 < 0.0001
RM score
Group 1 17.5 ± 5.3 14.1 ± 7.4 3.9 < 0.0001
Group 2 16.6 ± 5.9 11.8 ± 7.9 3.75 < 0.0001
WD (m)
Group 1 293.5 ± 206.9 604.4 ± 404.8 -4.6 < 0.0001
Group 2 234.1 ± 152.3 727.3 ± 495.6 -5.1 < 0.0001
VAS, visual analogue scale; LS, lumbar schober; FTF, finger-to-floor distance; Ext, extension; RM, Roland Morris score; WD, walking 
distance.
Table 3. The Comparison of Percent Changes in Both Groups
Group 1 Group 2 t p
VAS at rest 54.6 ± 40.4 49.89 ± 33.5 0.39 > 0.05
VAS with motion 45.7 ± 28.2 53.6 ± 21.9 -1.04 > 0.05
LS (cm) 2.9 ± 19.2 10.3 ± 20.3 1.26 > 0.05
FTF (cm) 44.6 ± 41.1 16.9 ± 59.6 1.43 > 0.05
Ext (degree) 39.5 ± 29.03 37.5 ± 27.9 0.24 > 0.05
RM score 24.7 ± 33.1 32.9 ± 34.6 -0.81 > 0.05
WD (m) 40.8 ± 32.9 6 ± 56.2 ± 31.8 -1.61 > 0.05
VAS, visual analogue scale; LS, lumbar schober; FTF, Finger-to-floor distance; Ext, Extension; RM, Roland Morris score; WD, walking 
distance.
DISCUSSIONPhysical Therapy & Calcitonin in Spinal Stenosis
Yonsei Med J   http://www.eymj.org    Volume 50   Number 5   October 2009 687
33 months. The authors concluded that aggressive conser-
vative treatment was a good option. In a study by Tadokoro,
et al.,
27 inpatient conservative therapy was administered to
a group of patients with LSS over 70 years of age, and it
was concluded after a follow-up of 57 weeks, that particul-
arly those with radicular pain were good candidates for
conservative treatment, and had a relatively good prognosis.
Our study also combined the conservative treatment
options of physical therapy and exercise, and investigated
the additive effect of short-term calcitonin as an analgesic.
We administered low frequency currents for analgesia, Hot
Pack for superficial heat, and short-wave diathermia for
deep heat as physical therapy modalities. Exercises consis-
ting particularly of lumbar flexion, mobilization, and
stretching exercises were taught to patients during physical
therapy sessions, and adviced to be repeated at home. Cal-
citonin was given at a dose of 200 U/day as a nasal spray,
and evaluations were made at the end of 8 weeks. 
The use of calcitonin in LSS was first published by
Porter.
33 In this study, 10 patients with neurogenic claudi-
cation symptoms were found to have improved with calci-
tonin, and calcitonin was considered to be affective by
increasing the blood flow. A follwing study by Porter com-
pared 100 U calcitonin with plasebo in 42 patients, and
found no statistical significance although calcitonin inc-
reased walking distance.
12 A study by Eskola, et al.
13 with
15 patients followed for 3 months, also using 100 U calci-
tonin, and reported a decrease in pain and an increase in
performance. Another double-blind, randomized placebo-
controlled study by Eskola, et al.
34 followed 39 patients for
one year, and found that calcitonin was effective on the
parameters like pain and walking distance, but less effec-
tive in patients with a walking distance below 200-300
meters. In another randomized, double-blind, controlled
trial by Podichetty et al.
35 with 36 patients with a VAS
score over 6 which was observed for 6 weeks, no signifi-
cant difference was found between 2 groups in terms of
walking period, walking distance, or functional assess-
ment by SF-36. Walking distance was limited to 130 m in
this trial, and the authors suggested that an inadequate
efficacy of calcitonin might be due to the severity of symp-
toms in this patient group. In our study, although the average
pain score was 7.5 with VAS which was similar to other
studies, walking distance was an average of 300 m which
was longer than the others, i.e. symptom severity was also
lower than others. In spite of these differences, calcitonin
did not add any benefit to physical therapy and exercise
program. In the present study, the Roland-Morris score
used for functional assessment showed significant increase
in all patients, but there was no significant difference
between the 2 groups in terms of the percent change. 
A comparison between conservative treatment and sur-
gical therapy appears to be in favor of surgical therapy. In
a long-term study with a large patient number, Atlas, et
al.
36 followed, 119 of 148 patients for 4 years. The operated
group with more severe symptoms at baseline, compared
with the non-operated group at the end of 4 years, showed
significantly fewer symptoms, more treatment satisfaction,
and better functional status. In the non-surgical group,
improvement was modest and stable for 4 years. Amun-
dsen, et al.
25 followed 100 patients for 10 years, and reported
that operated patients showed better outcomes and patients
with severe symptoms especially benefited from surgery,
and that conservative therapy should be administered to
patients with moderate symptoms, as a delay in surgical
treatment did not have negative impact on the outcome.
In conclusion, in our 45 patients with an average age of
55 years, neurogenic claudication, and moderate LSS
symptoms in terms of walking distance, short-term
physical therapy and exercise therapy for 3 months signi-
ficantly improved pain, physical examination findings, and
walking distance and functional parameters. The addition of
200 U/day calcitonin did not lead to a significant impro-
vement in follow-up parameters. We, therefore, conclude
that the addition of calcitonin as an analgesic in the short-
term treatment of LSS along with physical therapy and
exercise administration is not necessary.  
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